SCHEMBL6463845

SCHEMBL6463845

CCCCCC[C@H](Cl)CC(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 12/20 0.62
FFAR1 O14842 3/20 0.50
FFAR4 Q5NUL3 2/20 0.50
PPARD Q03181 7/20 0.48
MAPT P10636 1/20 0.48
LCK P06239 1/20 0.48
ZDHHC20 Q5W0Z9 1/20 0.48
ZDHHC2 Q9UIJ5 1/20 0.48
PPARG P37231 6/20 0.46
PPARA Q07869 6/20 0.46
HDAC11 Q96DB2 5/20 0.46
TSHR P16473 4/20 0.46
ALDH1A1 P00352 2/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
FABP4 P15090 2/20 0.46
PTPN1 P18031 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46
MEN1 O00255 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6466759 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL6465804 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL29894891 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL1158455 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL28499460 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL6461561 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL6463301 0.98 GPR84 (0.59) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL29893958 0.98 GPR84 (0.59) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL4433437 0.98 GPR84 (0.59) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL6465070 0.91 GPR84 (0.50) GPR84FFAR1FFAR4PPARDPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6903233-B2 Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-07 US disclosed
US-20030225301-A1 Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester TAKASAGO INTERNATIONAL CORPORATION (JP) 2003-12-04 US disclosed
EP-1344763-A1 Process for producing optically active 3-halogenocarboxylic acid esters and 3-azide-carboxylic acid esters Takasago International Corporation (JP) 2003-09-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225301-A1 Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester HDHD5, APEH, AOC3 GPR84 3209/4885FFAR1 349/4885FFAR4 507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.